34,90 €
GHK-Cu – 2 mg (60 capsules) Premium research product containing a highly purified copper complex of the GHK-Cu tripeptide in a stable oral capsule form for precise laboratory dosing.
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring copper complex that is at the center of modern biomedical research in the field of longevity and cellular regeneration.
The oral capsule form is intended for advanced research focused on the systemic effects of this peptide complex – particularly its ability to modulate gene expression, promote deep tissue repair, protect the gastrointestinal mucosa, and exhibit strong antioxidant and anti-inflammatory properties at the level of the entire organism.
The product is intended exclusively for scientific, laboratory, and research purposes.
⚠️ IMPORTANT NOTICE:
This product is a chemical substance developed exclusively for laboratory, scientific, and research purposes. The product is not a medicine, is not a registered dietary supplement, and is not intended for human or veterinary use, direct consumption, or therapeutic applications. Improper handling may pose risks. Store in a dry and cool place, out of reach of children.
40 in stock
GHK-Cu – 60 capsules / 2 mg (Expanded systemic complex for tissue remodeling and epigenetics)
The copper tripeptide complex GHK-Cu is among the most intensively studied molecules in the fields of regenerative biology and longevity science. Levels of this natural peptide in the human body decline sharply with age, which is closely associated with the gradual deterioration of the organism’s regenerative capacity. While topical (skin) and injectable forms focus on local tissue remodeling, the oral capsule form (2 mg per capsule, total 120 mg blend per package) opens the possibility for researchers to study the complex systemic effects of GHK-Cu acting from within the organism.
This experimental product offers a stable and precisely dosed form for in vivo and in vitro research protocols, in which the distribution of copper peptides through the gastrointestinal tract and their subsequent integration into cellular signaling pathways is monitored.
Effects studied in science
The primary reason for studying oral administration of GHK-Cu is its specific behavior in the gastrointestinal tract and subsequent entry into the bloodstream:
Epigenetic modulation and cellular rejuvenation: Genetic studies show that GHK-Cu can control and “reset” the expression of more than 4,000 human genes. Research focuses on its ability to reverse age-related DNA damage and return the cellular profile of aging tissues to a healthier, more youthful state.
Systemic tissue and collagen remodeling: GHK-Cu acts as a key carrier of copper ions, which are essential cofactors for enzymes such as lysyl oxidase (responsible for collagen and elastin cross-linking). Capsule-based research examines how systemic action affects vascular elasticity, bone matrix strength, skin density, and connective tissue integrity from within.
Cytoprotection and gastrointestinal mucosal healing: A significant research direction focuses on GHK-Cu’s ability to accelerate the healing of damaged mucosal tissues. Its potential role in suppressing intestinal inflammation, regenerating the gastric wall, and supporting healthy epithelial barrier function is being studied.
Strong anti-inflammatory and antioxidant effect: In studies, GHK-Cu blocks the secretion of pro-inflammatory cytokines (such as IL-1, IL-6, TNF-alpha) and activates antioxidant enzymes (especially superoxide dismutase). In this way, it protects organ systems from chronic oxidative stress and so-called “inflammaging” (age-related inflammation).
Scientific context and sources
The discoverer of the exceptional properties of this molecule is world-renowned biochemist Dr. Loren Pickart, whose work laid the foundation for the medical use of copper peptides. Detailed analyses of GHK-Cu’s ability to regenerate organs, suppress cellular mutations, and remodel the extracellular matrix are published in prestigious scientific journals.
Hundreds of peer-reviewed studies, including publications in the International Journal of Molecular Sciences and the Journal of Aging Research, are available in the international PubMed database (search terms: “GHK-Cu systemic effects”, “GHK-Cu gene expression”, or “GHK-Cu tissue remodeling”).
Ongoing clinical studies and preclinical experimental models tracking the compound’s stability in the gastrointestinal environment and its non-toxic profile under controlled dosing are registered on ClinicalTrials.gov.
The Royal Peptides package contains 60 precisely calibrated capsules (2 mg GHK-Cu), manufactured under strict laboratory conditions ensuring maximum purity and stability of the active substance for controlled scientific research.
⚠️ IMPORTANT NOTICE:
This product is a chemical substance developed exclusively for laboratory, scientific, and research purposes. It is not a medicine, is not a registered dietary supplement, and is not intended for human or veterinary use, direct consumption, or therapeutic applications. Improper handling may pose risks. Store in a dry and cool place, out of reach of children.
